Stakeholders

Towards an extension of mandatory vaccination in Italy?

Monday, February 6, 2017 - 10:44

Immunization rates in Italy are decreasing at a worrying trend: international targets for measles eradication and safety thresholds in childhood vaccination are vanishing. Authorities, doctors and families are concerned that a coverage below 86% for MPR (measles, parotitis and rubella) vaccine can impair herd immunity, putting younger babies, immunocompromised people and not-responders at risk.

Target: 
Citizens, Government and Public Health, Healthcare Professionals, School and Education
Topic: 
Prevention, Stakeholders, Vaccination
Tags: 
Vaccine, Vaccine hesitancy, Vaccine safety, communication, engagement, public health

Zika: an emerging disease to be tackled both in laboratories and in society

January 24, 2017

Ilaria Capua, as director of the One Health Excellence Centre at the Emerging Pathogens Institute of the University of Florida, USA, is very busy in coordinating interdisciplinary research, facing the epidemic of zika virus disease spreading in South America and the Caribbean and reaching Florida. Scientists are testing new diagnostic tests and working on vaccines, but the risk of serious birth defects in the offspring of infected pregnant women calls also for responsible procreative choices, involving lawmakers, governments and religious leaders as well.

Target: 
Decision Makers, Government and Public Health, Healthcare Professionals
Topic: 
Epidemiology, Stakeholders, Vaccination
Tags: 
Video, zika, Vaccine, science-in-society

Sex, clinical trials and medicines regulation part III

Thursday, January 19, 2017 - 11:01

Gender issue in clinical trials in Europe

Internationally, the issue of including women in clinical trials of medicines has been addressed in various guidelines issued by the International Conference on Harmonization (ICH), which promotes regulatory standards for clinical trials. While ICH has specific guidelines on the conduct of clinical trials in paediatric and geriatric populations, there are no consolidated guidelines for the investigation of medicinal product in women.

Target: 
Government and Public Health, Healthcare Professionals
Topic: 
Gender, Human Rights, Policy, Stakeholders
Tags: 
gender issues, clinical trials, policy, transparency

Pandemic Legacy: what a game can teach us about pandemics

Thursday, January 12, 2017 - 09:08

Month by month, the diseases spread across the world, cities fall into panic and some of them are even wiped out by virulent outbreaks, while tenacious experts cooperate to find a cure before it’s too late.

Target: 
Citizens, Healthcare Professionals, Industry & Commerce, School and Education
Topic: 
Stakeholders
Tags: 
gamification, outbreak, pandemic, public health, risk communication

Sex, clinical trials and medicines regulation part II

Friday, December 30, 2016 - 10:24

Drug Approval Regulation in Canada and USA

Since the thalidomide tragedy in the late1950s, there has been a reluctance to include women of childbearing age in clinical trials. However, this fear cannot be used as an excuse to not include females in clinical trials, and, with proper care and regulation, increased female participation has been reached. The United States adopted regulation early on to increase the participation of women, while a new regulation in Europe is going to improve this as well. Here follows an overview of the issue in Canada and in the USA. The third part of this series will deal with new regulation in Europe.

Target: 
Decision Makers, Government and Public Health
Topic: 
Gender, Prevention, Stakeholders, Treatment, Vaccination
Tags: 
gender issues, clinical trials

Piero Bassetti: a pioneer of RRI in Italy

November 21, 2016

“You cannot use old categories to solve new problems”. Piero Bassetti, president of the Giannino Bassetti Foundation, has been one of the pioneers of the idea of Responsible Research and Innovation in Italy. He started talking about these issues many years before they became central in Science-with-and-for-Society policy at a European level. In this interview, he tells us how things have changed ever since.

Target: 
Industry & Commerce
Topic: 
Stakeholders
Tags: 
Video, science-in-society, research, innovation

Democracy and human rights in a Public Health Emergency

Saturday, November 19, 2016 - 10:19

This editorial introduces the new edition of ASSET paper series.

Human rights are at the very core of EU democracy. With the entry into force of the Lisbon Treaty in 2009, the Charter of Fundamental Rights of the EU became legally binding and the EU acceded to the European Convention on Human Rights. 

Target: 
Decision Makers, Government and Public Health
Topic: 
Human Rights, Policy, Stakeholders
Tags: 
public health, science-in-society

Engaging citizens in pandemic preparedness and response

Thursday, November 17, 2016 - 16:03

In the wake of the 2009-2010 H1N1-pandemic, also known as the swine flu, a web of mistrust between the public and health authorities was spun. National pandemic plans were usually based on a single scenario that was more severe than the actual 2009 pandemic, and that was extrapolated from the severity of previous outbreaks like SARS and Avian flu. In effect the 2009 pandemic was nicknamed the false-pandemic or ‘the pandemic there never was’. However, national health authorities had declared a pandemic and bought vaccines for billions.

Target: 
Citizens, Decision Makers, Government and Public Health, Healthcare Professionals
Topic: 
Citizens' Mobilization, Policy, Prevention, Stakeholders, Vaccination
Tags: 
citizen consultation, science-in-society, Vaccine, public health

Population consultation, two-way communication and decision

Some countries are slowly moving toward the implementation of a two-way PH communication strategy. For example, in May 2010, shortly after the H1N1 pandemic, the public health authorities of New Zealand designed a rapid response initiative to have feedback from population on the communication campaign and on their risk perception. The project consisted in a study, which aimed to retrieve evidence-based information which health authorities could use to design tailored health communication campaigns during/after periods of pandemics.

Country: 
New Zealand
Target: 
Citizens, Decision Makers, Government and Public Health, Healthcare Professionals
Topic: 
Local Activities, Stakeholders
Tags: 
communication, inequities

Changing the citizen behaviour to improve public health and increase vaccination awareness – Carta Italiana

A very recent and innovative example of good practice concerning awareness campaigns is the “Italian Chart for the Promotion of Vaccinations”, a recent call for action whose website is: http://www.teamvaxitalia.it/. Namely, the Chart is the result of the efforts of the “TeamVaxItaly” movement that had been founded in a civil society meeting in Fano (Italy) in October 2015.

Country: 
Italy
Target: 
Citizens, Decision Makers, Government and Public Health, Healthcare Professionals
Topic: 
Human Rights, Local Activities, Stakeholders, Vaccination
Tags: 
Vaccine, Vaccine hesitancy, Vaccine safety, best practice

Pages

Subscribe to Stakeholders

MMLAP and other EU Projects

AsiaFluCap
Health system analysis to support capacity development in response to the threat of pandemic influenza in Asia
BEWATER
Making society an active participant in water adaptation to global change
CASI
Public Participation in Developing a Common Framework for Assessment and Management of Sustainable Innovation
CIMULACT
Engaging all of Europe in shaping a desirable and sustainable future
DARWIN
Expect the unexpected and know how to respond
DRIVER
Driving innovation in crisis management for European resilience
ECOM
Effective communication in outbreak management: development of an evidence-based tool for Europe
EDEN
Solutions to improve CBRNe resilience
EPISOUTH
Network for Communicable Disease Control in Southern Europe and Mediterranean Countries
EPIWORK
Developing the framework for an epidemic forecast infrastructure
EUPHARE
Strengthening of the national surveillance system for communicable diseases
EUROHEP
Surveillance of vaccine preventable hepatitis
EuroMOMO
European monitoring of excess mortality for public health action
EURONHID
European network for highly infectious disease
EUVAC.NET
Dedicated surveillance network for surveillance and control of vaccine preventable diseases in the EU
FLUMODCONT
Modelling the spread of pandemic influenza and strategies for its containment and mitigation
FLURESP
Cost-effectiveness assessment of european influenza human pandemic alert and response strategies
GAP2
Bridging the gap between science, stakeholders and policy makers
HProImmune
Promotion of immunization for health professionals in Europe
INPROFOOD
Towards inclusive research programming for sustainable food innovations
JA-CHRODIS
Addressing chronic diseases and healthy ageing across the life cycle
M-Eco
Medical ecosystem – personalized event-based surveillance
MAPPING
Studying the many and varied economic, social, legal and ethical aspects of the recent developments on the Internet, and their consequences for the individual and society at large
MARINA
Get involved in the responsible marine research and innovation
PACITA
Knowledge-based policy-making on issues involving science, technology and innovation, mainly based upon the practices in Parliamentary Technology Assessment
PANDEM
Assessment of the current pandemic preparedness and response tools, systems and practice at national, EU and global level in priority areas
PE2020
Analysis of innovative public engagement tools and instruments for dynamic governance in the field of Science in Society
PERARES
Public Engagement with Research And Research Engagement with Society
PHEME
Computing Veracity – the Fourth Challenge of Big Data
PREPARE
Providing infrastructure, co-ordination and integration of existing clinical research networks on epidemics and pandemics
PROMOVAX
Promote vaccinations among migrant population in Europe
R&DIALOGUE
Creating mechanisms for effectively tackling the scientific and technology related challenges faced by society
RESPIRE
Improve the quality of indoor air, keeping it free from radon
SATORI
Improving respect of ethics principles and laws in research and innovation, in line with the evolution of technologies and societal concerns
SECURING CITIES AGAINST GLOBAL PANDEMICS
Investigating how cities in the West securitise against global pandemics
SEiSMiC
Creating a structured dialogue and mutual learning with citizens and urban actors by setting up National Networks in 10 countries across Europe
SIS CATALYST
Identifying how children can be change agents in the Science and Society relationship
SYN-ENERGENE
Establishing an open dialogue between stakeholders concerning synthetic biology’s potential benefits and risks
TELLME
Transparent communication in Epidemics: Learning Lessons from experience, delivering effective Messages, providing Evidence